Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125734821 | 12573482 | 1 | I | 20160624 | 20160720 | 20160720 | PER | US-PFIZER INC-2016319143 | PFIZER | 50.00 | YR | F | Y | 85.00000 | KG | 20160720 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125734821 | 12573482 | 1 | PS | AROMASIN | EXEMESTANE | 1 | Oral | 25 MG, DAILY | U | 20753 | 25 | MG | COATED TABLET | ||||||
| 125734821 | 12573482 | 2 | C | CLARITIN-D 24 HOUR | LORATADINEPSEUDOEPHEDRINE SULFATE | 1 | Oral | 1 DF, DAILY [LORATADINE 10 MG, PSEUDOEPHEDRINE SULFATE 240 MG] | 0 | 1 | DF | MODIFIED-RELEASE TABLET | |||||||
| 125734821 | 12573482 | 3 | C | DETROL LA | TOLTERODINE TARTRATE | 1 | Oral | 4 MG, DAILY | 0 | 4 | MG | MODIFIED-RELEASE CAPSULE, HARD | |||||||
| 125734821 | 12573482 | 4 | C | DIFLUCAN | FLUCONAZOLE | 1 | Oral | 150 MG, DAILY | 0 | 150 | MG | TABLET | |||||||
| 125734821 | 12573482 | 5 | C | ACETAMINOPHENHYDROCODONE BITARTRATE | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | 1 DF, AS NEEDED [HYDROCODONE BITARTRATE 10MG, PARACETAMOL 325 MG, Q4H] | 0 | 1 | DF | TABLET | |||||||
| 125734821 | 12573482 | 6 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, 2X/DAY | 0 | 5 | MG | TABLET | BID | ||||||
| 125734821 | 12573482 | 7 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Oral | 10 MEQ, 2X/DAY | 0 | 10 | MEQ | MODIFIED-RELEASE TABLET | BID | ||||||
| 125734821 | 12573482 | 8 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Oral | 20 MEQ, 2X/DAY | 0 | 20 | MEQ | MODIFIED-RELEASE TABLET | BID | ||||||
| 125734821 | 12573482 | 9 | C | PREVPAC | AMOXICILLINCLARITHROMYCINLANSOPRAZOLE | 1 | Oral | UNK [1 PACK PO AS DIRECTED] [AMOXICILLIN TRIHYDRATE 30, CLARITHROMYCIN 500, LANSOPRAZOLE 500] | 0 | ||||||||||
| 125734821 | 12573482 | 10 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 20 MG, DAILY | 0 | 20 | MG | CAPSULE | |||||||
| 125734821 | 12573482 | 11 | C | TAMOXIFEN CITRATE. | TAMOXIFEN CITRATE | 1 | Oral | 20 MG, DAILY | 0 | 20 | MG | TABLET | |||||||
| 125734821 | 12573482 | 12 | C | ZIPSOR | DICLOFENAC POTASSIUM | 1 | Oral | 25 MG, UNK [AS DIRECTED] | 0 | 25 | MG | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125734821 | 12573482 | 5 | Pain |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125734821 | 12573482 | Arthralgia | |
| 125734821 | 12573482 | Back pain | |
| 125734821 | 12573482 | Lymphoedema |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125734821 | 12573482 | 1 | 20121115 | 0 | ||
| 125734821 | 12573482 | 3 | 20130215 | 0 | ||
| 125734821 | 12573482 | 4 | 20121115 | 0 | ||
| 125734821 | 12573482 | 6 | 20120823 | 0 | ||
| 125734821 | 12573482 | 7 | 20131118 | 0 | ||
| 125734821 | 12573482 | 8 | 20131118 | 0 | ||
| 125734821 | 12573482 | 11 | 20120823 | 0 | ||
| 125734821 | 12573482 | 12 | 20121115 | 0 |